paxilline has been researched along with Cancer of Head in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, SD; Shin, JA; Yu, HJ | 1 |
| Asiedu, EB; Hefni, E; Ma, T; Meiller, T; Menon, D; Montaner, S; Schneider, A; Sodhi, A; Sultan, A | 1 |
| Bekiranov, S; Gioeli, D; Hall, S; Jameson, MJ; Lehman, CE; Petricoin, EF; Shaw, JJP; Spencer, A; Wulfkuhle, J | 1 |
| Dai, Y; Dudney, WC; Pierson, SE; Stack, BC | 1 |
| Cordes, N; Eke, I; Hehlgans, S | 1 |
| Donato, NJ; Johnson, FM; Saigal, B; Talpaz, M | 1 |
6 other study(ies) available for paxilline and Cancer of Head
| Article | Year |
|---|---|
Inhibition of focal adhesion kinase/paxillin axis by caffeic acid phenethyl ester restrains aggressive behaviors of head and neck squamous cell carcinoma in vitro.
Topics: Cadherins; Caffeic Acids; Cell Line, Tumor; Cell Movement; Focal Adhesion Protein-Tyrosine Kinases; Head and Neck Neoplasms; Humans; Paxillin; Phenylethyl Alcohol; Squamous Cell Carcinoma of Head and Neck | 2023 |
Angiopoietin-like 4 induces head and neck squamous cell carcinoma cell migration through the NRP1/ABL1/PXN pathway.
Topics: Angiopoietins; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Movement; Head and Neck Neoplasms; Humans; Neuropilin-1; Paxillin; Squamous Cell Carcinoma of Head and Neck | 2023 |
IGF1R and Src inhibition induce synergistic cytotoxicity in HNSCC through inhibition of FAK.
Topics: Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Dasatinib; Drug Synergism; Focal Adhesion Kinase 1; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Indoles; Paxillin; Phosphorylation; Protein Array Analysis; Pyrazoles; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Sulfonamides; Triazines | 2021 |
Extraribosomal function of metallopanstimulin-1: reducing paxillin in head and neck squamous cell carcinoma and inhibiting tumor growth.
Topics: Animals; Carcinoma, Squamous Cell; Cell Division; Cell Line, Tumor; Culture Media, Conditioned; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; Male; Metalloproteins; Mice; Mice, Nude; Neoplasm Proteins; Neovascularization, Pathologic; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Paxillin; Recombinant Fusion Proteins; Resting Phase, Cell Cycle; Ribosomal Proteins; RNA-Binding Proteins; RNA, Messenger; RNA, Neoplasm; Transfection | 2010 |
Targeting FAK radiosensitizes 3-dimensional grown human HNSCC cells through reduced Akt1 and MEK1/2 signaling.
Topics: Butadienes; Carcinoma, Squamous Cell; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Focal Adhesion Kinase 1; Head and Neck Neoplasms; Humans; MAP Kinase Kinase Kinase 1; MAP Kinase Kinase Kinase 2; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Molecular Targeted Therapy; Neoplasm Proteins; Nitriles; Paxillin; Phosphorylation; Proto-Oncogene Proteins c-akt; Radiation Tolerance; Tumor Stem Cell Assay | 2012 |
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Topics: Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Collagen; Crk-Associated Substrate Protein; Dasatinib; Dose-Response Relationship, Drug; Drug Combinations; Enzyme Inhibitors; Focal Adhesion Protein-Tyrosine Kinases; G1 Phase; Gentian Violet; Head and Neck Neoplasms; Humans; Immunoprecipitation; Inhibitory Concentration 50; Laminin; Lung Neoplasms; Neoplasm Invasiveness; Neovascularization, Pathologic; Paxillin; Phosphorylation; Protein-Tyrosine Kinases; Proteoglycans; Pyrimidines; Retinoblastoma Protein; S Phase; Signal Transduction; src-Family Kinases; Thiazoles; Time Factors; Trypan Blue | 2005 |